F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
NCT01254929 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 299
Last updated 2020-03-19
Summary
The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
Conditions
Interventions
- DEVICE
-
F-18 PET bone scan
Following the intravenous administration of approximately 10 mCi F-18, subjects will undergo an F-18 PET bone scan.
- DEVICE
-
Tc-99m bone scan
Following the intravenous administration of approximately 30mCi Tc-99m MDP, subjects will undergo a traditional bone scan on a gamma camera.
Sponsors & Collaborators
-
Seattle Nuclear Medicine
lead OTHER
Principal Investigators
-
David Djang, MD · Seattle Nuclear Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2014-02-28
- Completion
- 2020-03-31
Countries
- United States
Study Locations
More Related Trials
-
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939 ·Status: UNKNOWN
-
Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone
NCT00922519 ·Status: TERMINATED
-
FDG PET/CT in Breast Cancer Bone Mets
NCT01996046 ·Status: ACTIVE_NOT_RECRUITING
-
A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00847509 ·Status: COMPLETED ·Phase: NA
-
18F-NaF PET Imaging for Bone Scintigraphy
NCT01930812 ·Status: COMPLETED ·Phase: PHASE3
-
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
NCT02149173 ·Status: TERMINATED ·Phase: NA
-
18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery
NCT05174026 ·Status: COMPLETED ·Phase: NA
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
NCT01825902 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
18F-FSPG PET/CT for Cancer Patients on Therapy
NCT02599194 ·Status: COMPLETED ·Phase: PHASE2
-
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
NCT00392938 ·Status: COMPLETED
-
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
NCT00956163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
NCT01880762 ·Status: COMPLETED
-
Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
NCT02354326 ·Status: TERMINATED
-
Role of SPECT/CT of Bone Scan in Charactarization of Bone Lesions
NCT07248033 ·Status: NOT_YET_RECRUITING
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma
NCT00188929 ·Status: COMPLETED ·Phase: PHASE2
-
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
NCT04252859 ·Status: TERMINATED ·Phase: PHASE2
-
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830 ·Status: COMPLETED ·Phase: PHASE2
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
NCT04159376 ·Status: UNKNOWN ·Phase: NA
-
Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
NCT00180245 ·Status: COMPLETED
-
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
NCT00725387 ·Status: COMPLETED
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA